KPRX CIK: 1372514

Kiora Pharmaceuticals Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
0
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−14.2
FY22:
−12.3
FY23:
−12.6
FY24:
4.51
FY25:
−12.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−14.0
FY22:
−13.7
FY23:
−12.4
FY24:
5.66
FY25:
−12.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−13.8
FY22:
−13.6
FY23:
−12.5
FY24:
3.59
FY25:
−10.8

All amounts in millions USD Data source:SEC EDGAR